1363 studies found for:    Open Studies | "Hypertension"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypertension" (1363 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Primary Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Familial Primary Pulmonary Hypertension
Interventions: Drug: Diltiazem Hydrochloride;   Drug: Sugar Pill
2 Recruiting Registry for Pulmonary Hypertension in China
Conditions: Pulmonary Arterial Hypertension;   Chronic Thromboembolic Pulmonary Hypertension;   Death
Intervention:
3 Recruiting Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy
Conditions: Pulmonary Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Behavioral: exercise and respiratory therapy;   Other: sedentary control group
4 Unknown  Pharmacogenomics in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension;   PAH WHO Group I
Interventions: Drug: Sitaxsentan;   Drug: Bosentan, Ambrisentan
5 Recruiting Resistant Arterial Hypertension Cohort Study
Conditions: Hypertension;   Essential Hypertension;   Resistant Hypertension
Interventions: Drug: chlorthalidone;   Behavioral: motivational intervention for non-compliant individuals;   Drug: standardized anti-hypertensive treatment
6 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
7 Recruiting Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Pulmonary Arterial Hypertension;   Cardiovascular Diseases;   Lung Diseases;   Tanshinone IIA Sulfonate
Interventions: Drug: 20 mg sildenafil citrate by mouth;   Drug: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
8 Unknown  Endothelial Function in Patients With Pulmonary Arterial Hypertension
Conditions: Hypertension, Pulmonary;   Pulmonary Arterial Hypertension;   Functional Disorder;   Genetics
Interventions: Device: EndoPAT measurement;   Biological: Blood Test
9 Recruiting Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Conditions: Systemic Sclerosis;   Scleroderma;   Pulmonary Hypertension;   Pulmonary Arterial Hypertension
Intervention:
10 Not yet recruiting Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI.
Conditions: Pulmonary Arterial Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Drug: 11C-acetate;   Drug: [18F]Fluoro-2-deoxy-2-D-glucose;   Drug: MultiHance
11 Not yet recruiting Rapid Renal Sympathetic Denervation for Resistant Hypertension II
Conditions: Resistant Hypertension;   Uncontrolled Hypertension;   Renal Artery Ablation
Intervention: Device: Renal Denervation (OneShot™ Renal Denervation System)
12 Recruiting Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
Conditions: Hypertension, Pregnancy Induced;   Hydralazine Adverse Reaction;   Pre-eclampsia;   Pre-eclampsia Superimposed Pre-existing Hypertension
Interventions: Drug: Labetalol;   Drug: Hydralazine
13 Recruiting Haemodynamics in Hypertension
Conditions: Primary Hypertension;   Secondary Hypertension;   Aortic Stenosis;   Renal Insufficiency
Interventions: Drug: Nitroglycerin 0.25 mg (single dose);   Drug: Salbutamol 400 µg (single dose);   Drug: L-arginine (10 min infusion);   Dietary Supplement: Liquorice (2 weeks, glycyrrhizin 290-370 mg daily);   Dietary Supplement: Small milk casein-derived polypeptides (yoghurt, 12 weeks daily);   Drug: Bisoprolol (5mg daily for 3 weeks)
14 Not yet recruiting Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension Due to Left Ventricular Dysfunction
Conditions: Pre-capillary Pulmonary Hypertension;   Post-capillary Pulmonary Hypertension;   Left Ventricular Dysfunction
Interventions: Drug: Macitentan;   Drug: Placebo
15 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
16 Recruiting Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study
Conditions: Primary Hypertension;   Hypertension, Resistant to Conventional Therapy
Interventions: Drug: Herbs;   Drug: Thiazide diuretics and ACE inhibitor and β-blocker
17 Recruiting Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil
18 Recruiting Treatment of Masked Hypertension
Conditions: Masked Hypertension;   Hypertension;   Chronic Renal Insufficiency
Interventions: Other: Antihypertensive medication intensification;   Other: Usual care
19 Recruiting Optimizing Linkage and Retention to Hypertension Care in Rural Kenya
Conditions: Hypertension;   High Blood Pressure
Interventions: Behavioral: behavioral communication strategy;   Behavioral: Behavioral communication strategy, plus smartphone-based tool
20 Recruiting Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
Conditions: Hypertension, Resistant to Conventional Therapy;   Essential Hypertension
Interventions: Drug: Losartan and hydrochlorothiazide;   Drug: Hydrochlorothiazide switched over with Losartan at 8 weeks

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years